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Cell-CAM 105 (C-CAM), a cell adhesion molecule in rat hepatocytes, was digested with trypsin, and peptides were isolated and sequenced by 
Edman degradation. The sequences of 4 pegtides agreed with different regions of rat liver ecto-ATPase. Detailed biochemical analyses confirmed 
the identity between C-CAM and the ecto-ATPase. C-CAM/e&o-ATPase is a transmembrane protein having 4 immunoglobulin-like domains in 
the extracellular portian, demonstrating membership of the immunoglobulin superfamily. The ATPase activity suggests that ATP might influence 
cell adhesion, which would explain the inhibitory effect of exogenously added ATP on adhesion of several cell types. 
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1. INTRODUCTION 
Intercellular adhesion mediated by cell adhesion 
molecules (CAMS) is important in formation and 
maintenance of proper tissue structures, Work in recent 
years has demonstrated that the majority of CAMS that 
is involved in tissue formation belongs to two different 
families. The cadherin family [l] contains calcium- 
dependent proteins, whereas a number of calcium- 
independent CAMS are members of the im- 
munoglobulin (Ig) superfamily 121. Cell-CAM 105 (C- 
CAM) is a calcium-independent CAM with homophilic 
binding properties [3]. C-CAM mediates cell-cell adhe- 
sion of isolated rat hepatocytes f4] and is present in a 
variety of epithelia, vessel endothelia, granulocytes and 
platelets [5]. Whereas detailed chemical characteriza- 
tion has been reported [6], we have had insufficient se- 
quence information to determine the relationship of 
C-CAM to any established CAM-family. We now 
report on amino acid sequence dete~ination and 
chemical characterization demonstrating that C-CAM 
is identical to an ecto-ATPase in rat liver 171. The pro- 
tein contains 4 Ig-domains demonstrating that C-CAM 
belongs to the Ig-superfamily. 
and dissolved in 8 M urea/O.1 M NI&HC% The solution was 
diluted with 0.1 M NHaHCO3 to a final concentration of 2 M urea. 
Recrystallized, TPCK-treated trypsin was added to an enzyme :pro- 
tein ratio of 1: 50 (w/w), CaClz was added to yield 0.1 mM, and the 
samples were incubated for 24 h at 37°C. The digested material was 
fractionated by reversed-phase HPLC on a 30 x 2.1 mm Aquapore 
Butyl column (G) (Brow&e Labs Inc.) eluted with a linear O-70% 
acetonitrib gradient in water/O. 1 Vo trifluoroacetic acid. Six fractions 
denoted 1-6 were collected and separated on a 30 x 2.1 mm Spheri-5 
RP-18 column (Cle) (Brownlee Labs Inc.) eluted as the G-column. 
These fractions were denoted by a second number and were, if need- 
ed, finally separated on a Cls-column eluted with a linear O-50% 
acetonitrile gradient in water/0.9% NaCl. These fractions were given 
a third number. Five major peptides (l.f.2; 1.6.1; 3.4.4; 4.1.5; 4.2) 
were pure and were sequenced on an Applied Biosystems 470A gas 
phase protein sequencer utilizing Edman degradation. Released PTH- 
amino acids were analyzed by HPLC on a Merck Licrospher CS 
column. 
2.2. Cyanogen bromide cleavage, mi/d acid hydrolysis, rend 
SDS-PAGE 
Lyophilized C-CAM was dissolved in 70% formic acid. Cyanogen 
bromide was added to a final concentration of IO mg/ml. The 
samples were incubated for 24 h at room temperature; control in- 
cubation was done in the absence of cyanogen bromide. Mild acid 
hydrolysis of C-CAM was performed by incubating the protein in 
70% formic acid for 48 h at 37°C. After incubation, 10 vols of water 
were added, the samples were lyophilized and dissolved in 4% 
SDS/O.01 Vo Bromophenol blue/lO% glycerol/O.0625 M Tris-HQ, 
pH 8.3. Reduced and alkylated samples were electrophoresed in SDS 
on 10% polyacrylamide gels, develaped by silver staining, as 
previoudy described [6]. 
2. MATERIALS AND METHODS 
2. f . Peptide isolation and seguem5rrg 
3. RESULTS AND DISCUSSION 
C-CAM was purified from rat liver and detergent was changed 
from Triton X-100 to octylglucoside as previously described [6]. The 
protein was dialysed against 10% 2-propanol/O. 1Vo NH3, lyophilized 
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C-CAM was purified from rat liver membranes by a 
procedure that by all applied criteria has been 
demonstrated to yield a pure protein [6] ; see also 
Fig. 1, lane 1. Such purified C-CAM consists of twa 
peptide chains of apparent molecular masses of 105 000 
and 110000, respectively, that by peptide mapping were 
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Fig. 1. SDS-PAGE of peptides derived by cyanogen bromide 
cleavage or mild acid treatment of purified C-CAM. The molecular 
masses indicated to the left refer to lanes 1 and 2, and those to the 
right refer to lanes 3 and 4. (Lane 1) C-CAM incubated with 70% 
formic acid for 24 h at room temperature. The 105 kDa component 
represents uncleaved C-CAM. (Lane 2) C-CAM incubated with 
cyanogen bromide (10 mg/ml) in 70% formic acid for 24 h at room 
temperature. Two major peptides of 68 kDa and 36 kDa were 
formed. The minor band just below the 68 kDa peptide has the 
expected size that would result from a partial cleavage of the 
Met-Cys bond at position 166-167 in the 68 kDa peptide. (Lane 3) 
Purified, non-treated C-CAM. (Lane 4) C-CAM incubated with 70% 
formic acid for 48 h at 37°C. Five major bands with mean molecular 
masses of 89 kDa, 54 kDa, 50 kDa, 46 kDa and 40 kDa were 
observed. 
shown to be structurally similar [a]. The pure C-CAM 
was digested with trypsin and 5 peptides were isolated 
and sequenced. None of the sequences was found in a 
computer search of the NBRF protein sequence data 
base. Recently, however, Lin and Guidotti [7] publish- 
ed the deduced amino acid sequence of a cloned rat 
liver ecto-ATPase having biochemical properties strik- 
ingly similar to those of C-CAM. When we analyzed 
this sequence we found the complete sequences of 4 of 
the 5 C-CAM peptides represented in different parts of 
the 5 19 amino acid long ecto-ATPase (Table I). On fur- 
ther comparison of C-CAM and the ecto-ATPase we 
made the following observations, which strengthened 
the conclusion that these proteins are identical. 
(1) Both C-CAM and the ecto-ATPase are localized 
to the bile canalicular membranes in adult rat liver 
[5,8]. (2) Both proteins have the same apparent 
molecular mass [6,7]. (3) C-CAM contains 33% N- 
linked carbohydrate [6] and chemical determination in- 
268 
dicated that there should be approximately 15 oligosac- 
charides per peptide chain [9]. The ATPase has 16 
potential N-glycosylation sites [7]. (4) The two peptide 
chains of C-CAM have apparent molecular masses of 
54000 and 58000 after deglycosylation [6]. The 
molecular mass of the peptide chain of the ATPase is 
57388 and 53410 if the leading signal sequence is 
removed [7]. (5) The amino acid composition of C- 
CAM [6] is almost identical to that calculated from the 
ecto-ATPase sequence. The only significant exception 
is glycine which amounted to 12.3 mole% in C-CAM, 
but only to 5.8 mole% in the ATPase. Glycine is, 
however, a common contaminant in amino acid deter- 
minations. (6) The amino acid composition suggests 
that C-CAM has 5-6 methionine residues per peptide 
chain [6], which would yield a maximum of 6-7 pep- 
tides after CNBr-cleavage. However, only two major 
peptides with apparent molecular masses of 68000 and 
36000 were obtained (Fig. 1). This fits well with the 
amino acid sequence of the ecto-ATPase. The ATPase 
has 5 methionine residues including one in the N- 
terminal position. Of these only the Met-Glu bond at 
position 157-158 should be cleaved efficiently by CNBr 
in 70% formic acid [lo]. The other bonds, a Met-Cys 
at position 166-167 and especially the Met-Ser at posi- 
tion 88-89 and the Met-Thr at position 368-369 are 
cleaved very inefficiently under these conditions [lo]. 
Cleavage of the Met-Glu bond should yield two pep- 
tides with molecular masses of approximately 70000 
and 30000 when glycosylation is taken into account. (7) 
A consistent feature of purified C-CAM is that it is 
readily cleaved to several fragments by mild acid treat- 
ment. After hydrolysis in 70% formic acid at 37°C for 
48 h C-CAM was completely degraded, and in SDS- 
PAGE we observed 5 major, incompletely resolved 
Table 1 
Comparison of the amino acid sequences of C-CAM peptides with rat 
liver ecto-ATPase 
Peptide 4.2 
- X- L- P- Q- E- F- Q- V- F- Y- 
(57)- N- L- P- Q- E- F- Q- V- F- Y- (66) 
Peptide 4.1.5 
- A- Y- T- L- S- V- F- D- Q- Q- F- N- P- 
- I - Q- T- X- V- Q- F- 
(119)- A- Y- T- L- S- V- F- D- Q- Q- F- N- P- 
- I - Q- T- S - V- Q- F- (138) 
Peptide 3.4.4 
- X- L- F- N- S- Q- X- L- Q- L- T- 
(355)- W- L- F- N- S- Q- S- L- Q- L- T- (365) 
Peptide 1.61 
- A- Y- F- L- Y- 
(444)- A- Y- F- L- Y- (448) 
The sequences are written in the single letter code for amino acids. 
The sequence of the respective C-CAM peptide is shown in bold 
letters in the upper row. X indicates that the amino acid in this 
position could not be identified. The sequence of the ecto-ATPase [7] 
is given in the lower row. The amino acid positions in the 519 amino 
acid long ecto-ATPase are indicated on the left and right margins 
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bands having mean molecular masses of 89 kDa, 
54 kDa, 50 kDa, 46 kDa and 40 kDa (Fig. 1). Three 
Asp-Pro bonds, which are sensitive to mild acid 
hydrolysis [IO], are present in the ATPase. Cleavage of 
these bonds would be expected to give rise to maximally 
6 glycosylated peptides with predicted molecular 
masses of approximately 89 kDa, 86 kDa, 53 kDa, 
48 kDa, 41 kDa and 38 kDa, and 3 .non-glycosylated 
peptides of smaller size (15 kDa, 12 kDa and 4 kDa). 
Given the uncertainty in the calculated molecular 
masses due to the glycosylation there is thus good 
agreement between the peptide patterns observed for C- 
CAM and predicted for the ATPase. (8) C-CAM can be 
phosphorylated on serine residues 161. The ATPase has 
one potential CAMP-dependent phosphorylation site 
171. 
The most plausible explanation for not finding the 
sequence of the fifth C-CAM peptide (1.1.2) in the 
ecto-ATPase sequence is that this peptide was derived 
from the larger of the two C-CAM chains. The publish- 
ed ecto-ATPase sequence would then correspond to the 
smaller of the C-CAM chains, which is the most abun- 
dant [6]. Given the structural similarities between the 
two C-CAM chains it is possible that the other 4 C- 
CAM peptide sequences also occur in the larger C- 
CAM chain. If true, C-CAM would thus be analogous 
to the cell adhesion molecules MAG and N-CAM, 
which both belong to the immunoglobulin superfamily. 
As a result of alternative splicing 2 slightly different 
chains of MAG [ 111 and at least 5 different forms of N- 
CAM [2] have been found to exist. 
The ecto-ATPase is the rat homologue of human 
biliary glycoprotein 1 (BGPl) [12]. These proteins are 
members of the carcinoembryonic antigen (CEA) gene 
family, which is a subf~ily in the Ig-superfamily [ 131. 
The ecto-ATPase (C-CAM) and BGPl contain four Ig- 
domains, one V-domain and three CZ-domains 17,121. 
CEA has seven Ig-domains, one V-domain and six 
CZdomains [12]. It has recently been shown that CEA 
can serve as a calcium-independent cell adhesion 
molecule with homophilic binding properties [ 141. Pro- 
teins in the CEA gene family thus seem to constitute a 
novel subfamily of cell adhesion molecules in the Ig- 
superfamily. 
What is the role of the ATPase activity of C-CAM? 
An interesting possibility is that it might regulate the 
adhesive function of the molecule. It has in fact been 
demonstrated that exogenously added ATP inhibits cell 
adhesion of mouse liver cells [15] and chick embryo 
fibroblasts 1161, whereas ADP has a stimulating activi- 
ty. The triggering effect of ADP on platelet aggregation 
is well-known. More recently, it has been demonstrated 
that exogenously added ATP leads to adhesion- 
stimulated phosphorylation of two external proteins on 
HeLa cells [17], one of which has an apparent 
molecular mass of 105000. Furthermore, N-CAM on 
brain cells is probably a substrate for ATP-dependent 
phospho~lation by ecto-kinases 1181, and contactin, a 
130 kDa glycoprotein in chick interneuronal contacts, 
has been shown to contain a potential nucleotide- 
binding site in the extracellular domain [ 191. It has also 
been demonstrated that several cell types such as 
platelets, granulocytes and neurons can secrete ATP 
[18,20,21]. In view of these observations, it seems 
plausible that cells might control their adhesive interac- 
tions in a dynamic manner by localized, regulated 
ATP-secretion. We accordingly propose that C-CAM is 
one of the actors in ATP-regulated cell adhesion. In- 
teractions between the Ig-domains of C-CAM may be 
the structural basis for the specific homophilic binding. 
Binding and hydrolysis of ATP may then modify this 
binding in a manner similar to the ATP-regulated bin- 
ding between actin and myosin. It will be interesting to 
see if cell adhesion molecules other than C-CAM have 
ecto-ATPase activity. 
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